{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:43:19Z","timestamp":1780670599191,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ejim.2011.02.021","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T04:49:04Z","timestamp":1300250944000},"page":"471-477","source":"Crossref","is-referenced-by-count":12,"title":["Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"22","author":[{"given":"Fu-Chun","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzung-Dau","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Kuang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuh-Yuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jone","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Fong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.02.021_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.02.021_bb0010","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.02.021_bb0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ahj.2009.12.020","article-title":"Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100C\/ADP","volume":"159","author":"Moerenhout","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2011.02.021_bb0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1538-7836.2005.01751.x","article-title":"High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome","volume":"4","author":"Cuisset","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0025","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0030","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1538-7836.2008.03112.x","article-title":"Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI","volume":"6","author":"Campo","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.02.021_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.02.021_bb0045","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2005.01.030","article-title":"The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting","volume":"45","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.thromres.2005.10.011","article-title":"Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6months prospective study","volume":"118","author":"Gianetti","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2011.02.021_bb0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2141.2001.02728.x","article-title":"Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study","volume":"113","author":"Elwood","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1055\/s-0038-1657653","article-title":"Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD)","volume":"78","author":"Meade","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","article-title":"Platelet activation: assessment and quantification","volume":"22","author":"Kamath","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2011.02.021_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0029-1145254","article-title":"Clinical utility of the PFA-100","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/0953710021000057866","article-title":"Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients","volume":"13","author":"Ziegler","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.ejim.2011.02.021_bb0080","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2005.12.085","article-title":"Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study","volume":"48","author":"Campo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0085","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1538-7836.2006.02239.x","article-title":"Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS","volume":"4","author":"Fuchs","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0090","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1067\/mlc.2001.117406","article-title":"Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction","volume":"138","author":"Jilma","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2011.02.021_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH09-05-0285","article-title":"The influence of clinical characteristics, laboratory and inflammatory markers on \u2018high on-treatment platelet reactivity\u2019 as measured with different platelet function tests","volume":"102","author":"Elsenberg","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0105","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.02.021_bb0110","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000141575.92958.9C","article-title":"Platelet function predicts myocardial damage in patients with acute myocardial infarction","volume":"110","author":"Frossard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.02.021_bb0115","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2011.02.021_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09537100701504095","article-title":"Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy","volume":"19","author":"Christie","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.ejim.2011.02.021_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH08-03-0198","article-title":"Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.02.021_bb0140","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2011.02.021_bb0145","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1538-7836.2004.01046.x","article-title":"Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100","volume":"2","author":"Raman","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2011.02.021_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ejim.2009.09.005","article-title":"New antiplatelet agents: why they are needed","volume":"20","author":"Franchini","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2011.02.021_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejim.2010.06.007","article-title":"New antiplatelet agents in acute coronary syndromes (ACS): an update","volume":"21","author":"Mannucci","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2011.02.021_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/hrt.2010.195438","article-title":"Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"97","author":"Siller-Matula","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2011.02.021_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2003.09.002","article-title":"Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation","volume":"111","author":"Van der Planken","year":"2003","journal-title":"Thromb Res"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T04:24:32Z","timestamp":1560054272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0953620511000537"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.02.021","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}